These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13845470)

  • 1. [The increase of thrombin inhibitor in the blood after percutaneous administration of a heparinoid].
    WITTE S; BRESSEL D
    Klin Wochenschr; 1960 May; 38():501. PubMed ID: 13845470
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE ANTITHROMBIN EFFECT OF HEPARINOIDS IN VIVO. 3. ON THE MECHANISM OF ACTION OF HEPARINOIDS].
    PULVER R
    Arzneimittelforschung; 1963 Nov; 13():1010-1. PubMed ID: 14210418
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF HEPARIN, HEPARINOIDS, AND OTHER ELECTRONEGATIVE COMPOUNDS ON THE IN VITRO THROMBIN-FIBRINOGEN CONVERSION AND ON WHOLE BLOOD CLOTTING TIME.
    SALAFSKY B; LOOMIS TA
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():107-17. PubMed ID: 14204484
    [No Abstract]   [Full Text] [Related]  

  • 5. PERCUTANEOUS ABSORPTION OF HEPARIN IN RABBIT'S EAR.
    KONTTINEN Y
    Ann Med Exp Biol Fenn; 1965; 43():43-8. PubMed ID: 14312355
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect in man of a new heparinoid, treburon.
    FIELD JB; RAMSAY GD; ATTYAH AM; STARR P
    J Lab Clin Med; 1953 Feb; 41(2):208-14. PubMed ID: 13035252
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the hydrolytic activity of thrombin by chitin heparinoids.
    Nishimura S; Nishi N; Tokura S; Okiei W; Somorin O
    Carbohydr Res; 1986 Nov; 156():286-92. PubMed ID: 3815407
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the hemostatic defect caused by anticoagulants by evaluation of the intensity of the hemorrhage. I. Direct anticoagulants (heparin and synthetic heparinoids)].
    FRANDOLI G
    G Gerontol; 1962 Jul; 10():733-43. PubMed ID: 13959207
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of a natural heparinoid with sodium and calcium heparin for their effect on the inhibitor of activated factor X.
    Mannucci PM; di Santo C; Franchi F
    Experientia; 1976 Nov; 32(11):1478-80. PubMed ID: 62674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the interaction between blood platelets and heparinoids].
    HOLEMANS R; DEPREZ A
    Rev Hematol; 1960; 15():192-200. PubMed ID: 14402587
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of cutaneously applied hyaluronidase on thrombin inhibitor and the clearing factor of human plasma].
    STUETTGEN G; BRUESTER H
    Arch Klin Exp Dermatol; 1960; 210():27-33. PubMed ID: 13835418
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ANTICOAGULANT DRUG THERAPY IN MYOCARDIAL INFARCT].
    MATSUOKA S; HOMMA T
    Sogo Rinsho; 1964 Mar; 13():463-71. PubMed ID: 14140834
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the detection of local and systemic actions of heparin as well as heparinoid ointments].
    STUETTGEN G; BRUESTER H; SCHULGEN W
    Arzneimittelforschung; 1962 Jul; 12():723-7. PubMed ID: 13917990
    [No Abstract]   [Full Text] [Related]  

  • 17. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticurarimimetic action of heparin and synthetic heparinoids in the rabbit].
    CHEYMOL J; BOURILLET F; LEVASSORT C
    J Physiol (Paris); 1955; 47(1):132-6. PubMed ID: 13243278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the clarifying activity in vitro of serum after the addition of various heparinoid substances].
    WOLFF R; BRIGNON JJ
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():255-67. PubMed ID: 13845713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.